Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Veteran's prostate cancer rating was reduced from 100% to 20%, effective March 1, 2011. The reduction was proper as the evidence showed no local reoccurrence or metastasis of the prostate cancer and that the disability was not manifested by renal dysfunction, urine leakage, or obstructed voiding.

The deciding factor: The VA determined that there was no new evidence to support a higher rating for the Veteran's service-connected prostate cancer, as his symptoms did not meet the criteria for a higher rating based on the severity of his condition.

Claimed conditions
prostate cancer
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
20%
Decision date
May 31, 2016
Citation
1621716

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1621716.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.